Fletcher Spaght Ventures

FSV Overview

Investment Strategy

Our Team

Advisory Board

Industry Experience

Portfolio Companies


Portfolio Companies

Juventas Therapeutics, Inc.

Juventas Therapeutics

Cleveland, OH

Juventas Therapeutics is developing novel biopharmaceutical therapies for regenerative medicine using technology exclusively licensed from the Cleveland Clinic. The Company’s lead product, Stromal Derived Factor-1 (SDF-1), has been shown to significantly increase cardiac function through promoting cell survival and revascularization after myocardial infarction.

Copyright © 2015 Fletcher Spaght Ventures, LP
All Rights Reserved.
222 Berkeley Street • 20th Floor • Boston, MA 02116
617-247-6700 Telephone • 617-247-7757 Facsimile